This is the text extract for Notification of tramadol funding decision., browse documents here.

2 March 2010

Notification of tramadol funding decision

PHARMAC is pleased to announce its decision to fund tramadol hydrochloride 50 mg capsules from 1 June 2010, as a result of awarding the Invitation to Tender dated 21 December 2007 (2007/08 Tender) to the Arrow-Tramadol brand. Please note that there are other strengths and presentations of tramadol, including sustained-release tablets, oral liquid and injections, which are not currently funded. We are considering re-tendering some or all of these presentations in the 2010/2011 tender round.

Details of the decision · The Arrow-Tramadol brand of tramadol hydrochloride 50 mg capsules will be listed in Section B, and in Part II of Section H, of the Pharmaceutical Schedule from 1 June 2010 at the following price and subsidy (ex-manufacturer, excluding GST):

Pharmaceutical Brand Form and Strength Pack Size Price and subsidy

Tramadol hydrochloride

Arrow-Tramadol

Cap 50 mg

100

$6.95

· ·

Arrow-Tramadol will be fully funded without restriction; and Arrow-Tramadol will have Sole Supply Status from 1 September 2010 to 30 June 2011 and Hospital Supply Status from 1 August 2010 to 30 June 2011, with a 1% discretionary variance limit.

A summary of this decision will also be included in the April Tender Notification, in line with the usual tender notification timelines.

More information If you have any questions about this decision, you can call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.

A333057

Page 1 of 1